Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

116.51
Delayed Data
As of Sep 28
 -0.11 / -0.09%
Today’s Change
114.00
Today|||52-Week Range
157.99
-24.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash244.7M210.2M481.8M576.8M
 
 
 
 
 
Short Term Investment Cash-982.0K-27.3M271.7M94.9M
 
 
 
 
 
Cash & Short Term Investments560.5M632.4M920.2M1.2B
 
 
 
 
 
 
ReceivablesReceivables126.2M163.5M262.3M283.6M
 
 
 
 
 
 
InventoriesInventories110.5M118.7M123.0M141.7M
 
 
 
 
 
 
Current AssetsPrepaid Expenses8.0M7.9M8.0M9.8M
 
 
 
 
 
Other Current Assets104.6M128.8M200.4M213.9M
 
 
 
 
 
Current Assets909.8M1.1B1.5B1.9B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross356.1M364.6M369.6M376.6M
 
 
 
 
 
Depreciation-210.8M-213.2M-216.5M-217.1M
 
 
 
 
 
Intangible Assets22.9M23.9M20.4M15.5M
 
 
 
 
 
Other Assets44.3M76.7M66.7M31.8M
 
 
 
 
 
Total Assets1.1B1.3B1.7B2.2B
 
 
 
 
 
 
LiabilitiesAccounts Payable19.4M20.8M19.5M18.9M
 
 
 
 
 
Short Term Debt11.3M12.0M912.0K0.00
 
 
 
 
Accrued Expenses7.7M9.7M17.0M17.2M
 
 
 
 
 
Other Current Liabilities124.8M173.6M195.7M183.7M
 
 
 
 
 
Other Liabilities192.5M253.3M310.0M245.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt17.3M5.9M5.0M0.00
 
 
 
 
Deferred Taxes-3.6M-3.2M-2.3M-1.8M
 
 
 
 
 
Other Liabilities1.3M862.0K785.0K27.0K
 
 
 
 
 
Total Liabilities215.7M263.8M320.4M250.9M
 
 
 
 
 
 
EquityMinority Interest-664.0K-472.0K-577.0K-339.0K
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity886.3M1.0B1.4B1.9B
 
 
 
 
 
Total Shareholder Equity886.3M1.0B1.4B1.9B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding44.8M42.8M42.8M42.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.